Clarius Group, LLC DNLI — DENALI THERAPEUTICS INC

Ownership history in Clarius Group, LLC  ·  19 quarters on record

AI Ownership Summary

Clarius Group, LLC reported DENALI THERAPEUTICS INC (DNLI) in 19 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.84% in 2024 Q3. The latest visible filing shows DNLI at 0.35% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this DNLI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Clarius Group, LLC's position in DENALI THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

DNLI was reported at 0.35% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.84% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

DNLI stock page Clarius Group, LLC fund profile Clarius Group, LLC full holdings
How Clarius Group, LLC held DNLI — position size vs. price
% of Fund (quarterly)    DNLI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED — — — 368,995 +9,250 +2.6% 0.35% $6.1M 2026-02-14 (Est.) $18.77
2025 Q3 REDUCED — — — 359,745 -9,250 -2.5% 0.31% $5.2M 2025-10-14 $15.21
2025 Q2 UNCHANGED — — — 368,995 — 0% 0.30% $5.2M 2025-07-22 $13.87
2025 Q1 REDUCED 10.0% +2.9% ❌ 368,995 -41,000 -10.0% 0.32% $5.0M 2025-04-18 $12.74
2024 Q4 UNCHANGED — — — 409,995 — 0% 0.57% $8.4M 2025-01-16 $21.67
2024 Q3 UNCHANGED — — — 409,995 — 0% 0.84% $11.9M 2024-10-09 $26.52
2024 Q2 ADDED — — — 409,995 +17,777 +4.5% 0.67% $9.5M 2024-07-11 $23.09
2024 Q1 ADDED — — — 392,218 +13,956 +3.7% 0.56% $8.0M 2024-04-17 $16.82
2023 Q4 UNCHANGED — — — 378,262 — 0% 0.67% $8.1M 2024-01-29 $17.52
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding DNLI

As of 2026 Q1 — sorted by position size

Lynx1 Capital Management LP 3Y 5.71% 1492 Capital Management LLC 3Y 7Y 0.49% Candriam S.C.A. 3Y 7Y 0.11% China Universal Asset Management Co., Ltd. 3Y 0.06% Aberdeen Group plc 3Y 7Y 0.06% CONTRAVISORY INVESTMENT MANAGEMENT, INC. 3Y 7Y 0.06% Pictet Asset Management Holding SA 0.05% PROFUND ADVISORS LLC 3Y 7Y 0.05% Breakwater Capital Group 3Y 0.04% AlphaQuest LLC 0.04%

FAQ About Clarius Group, LLC and DNLI

These are the practical questions this page is built to answer before you even open the full history table.

How long has Clarius Group, LLC reported owning DNLI?

Clarius Group, LLC reported DNLI across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported DNLI position in Clarius Group, LLC's portfolio?

The largest reported portfolio weight for DNLI was 0.84% in 2024 Q3.

What is the latest reported DNLI position on this page?

The most recent filing on this page is 2025 Q4, when Clarius Group, LLC reported 368,995 shares, equal to 0.35% of portfolio, with an estimated market value of $6.1M.

What does the chart on this DNLI ownership page compare?

The chart compares Clarius Group, LLC's quarterly DNLI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Clarius Group, LLC time their DNLI position?

Based on 13F filing dates vs. subsequent DNLI price moves, Clarius Group, LLC correctly timed 4 out of 12 reported position changes (33%). The annualised alpha on DNLI relative to SPY over the holding period was -28.4%.

← Back to Clarius Group, LLC Holdings